- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04330014
Factor Affecting Childhood Immunization Among Childern.
March 31, 2020 updated by: Gehad Gamal Ahmed, Assiut University
Factor Affecting Childhood Immunization Among Childern Below Two Years
The aim of study to evaluate the factor affecting underutalization of childhood vaccination immunization among childern below two years of age.
Study Overview
Detailed Description
Childhood vaccination has proven to be one of the most effective public health strategies to control and prevent disease.1-5
In an effort to reduce childhood morbidity and mortality, the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) issues annual recommendations and guidelines for childhood and adolescent immunizations.2,6-8
However, some parents decline or delay vaccinating their children or follow alternative immunization schedules because of medical, religious, philosophical, or socioeconomic reasons.2,3,4,5,7,9-12Health
care provider-based interventions have been suggested to overcome such vaccine noncompliance, including patient counseling; improving access to vaccinations; maximizing patient office visits; offering combination vaccines; and using electronic medical records (EMRs) and practice alerts.2,3,4,7,10,11
Community- and government-based interventions to improve parent and patient adherence include public education and reminder/recall strategies, financial incentives, and providing alternative venues for vaccination.2,7.
Study Type
Observational
Enrollment (Anticipated)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Gehad Gamal, master
- Phone Number: 01006011751
- Email: gehadgamal098@gmail.com
Study Contact Backup
- Name: Gehad Gamal, master
- Phone Number: o1oo6011751
- Email: gehadgamal098@gmail.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 month to 2 years (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
childern below two years
Description
Inclusion Criteria:
- All childern in first two years of life who admmitted in hospital or out patient clinic.
Exclusion Criteria:
- : Immunodeficiency (e.g chemotherapy,long term immuno suppressive therapy, hematologic tumor).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Comparison between childern below two years who took vaccinations and those who didnot.
Time Frame: Baseline
|
The investigators evaluate factors effect of vaccine on the child as scioeconomic status, poverty, chronic disease and residance.
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Mohamed Mahmoud, professor, Assiut University
- Principal Investigator: Ismail Lotfy, professor, Assiut University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
January 1, 2021
Primary Completion (Anticipated)
January 1, 2022
Study Completion (Anticipated)
May 1, 2022
Study Registration Dates
First Submitted
March 30, 2020
First Submitted That Met QC Criteria
March 31, 2020
First Posted (Actual)
April 1, 2020
Study Record Updates
Last Update Posted (Actual)
April 1, 2020
Last Update Submitted That Met QC Criteria
March 31, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- Child Immunization
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Child Immunization
-
University of California, Los AngelesCenters for Disease Control and PreventionCompletedImmunization Status | Well Child Care Visit
-
The Hospital for Sick ChildrenBill and Melinda Gates Foundation; Aga Khan UniversityActive, not recruitingUnder Five Child Health Nutrition and ImmunizationPakistan
-
University of UtahCenters for Disease Control and Prevention; Utah Department of HealthCompletedUp-to-date Immunization Status for Children in Child CareUnited States
-
University of Alabama at BirminghamCompletedChildhood Immunization Completion | Childhood Immunization Dropout | Immunization Card | Center Based EducationPakistan
-
Duke UniversityUniversity of South Carolina; Fogarty International Center of the National... and other collaboratorsCompletedImmunizationTanzania
-
CAMC Health SystemCompleted
-
Auburn UniversityAgency for Healthcare Research and Quality (AHRQ)CompletedImmunizationUnited States
-
Lifespan Healthcare Resource LimitedUnknown
-
Children's Hospital of PhiladelphiaThrasher Research FundCompleted
-
Florida State UniversityCompletedImmunizationUnited States
Clinical Trials on vaccine
-
Butantan InstituteUniversity of Sao Paulo; Hospital Universitario da USPCompleted
-
Sinovac Biotech Co., LtdCompleted
-
GlaxoSmithKlineCompletedMalaria | Malaria VaccinesGhana, Burkina Faso
-
University of OxfordMalaria Research and Training Center, Bamako, MaliRecruiting
-
GlaxoSmithKlineIQVIA, USAActive, not recruitingChickenpoxTaiwan, Poland, United States, Estonia, Puerto Rico, Mexico
-
China National Biotec Group Company LimitedPeking University; Wuhan Institute of Biological Products Co., Ltd; Guizhou Center... and other collaboratorsCompletedEnterovirus Infections | InfluenzaChina
-
Sun XinActive, not recruitingVaccine Adverse ReactionChina
-
GlaxoSmithKlineCompletedInfections, PapillomavirusFinland
-
University of California, San FranciscoCompletedHematopoietic Stem Cell TransplantUnited States
-
NovartisNovartis VaccinesCompletedJapanese Encephalitis | Rabies | Pre-Exposure ProphylaxisThailand